| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9697 | 
      | Human Intestinal Absorption | HIA+ | 0.7462 | 
      | Caco-2 Permeability | Caco2- | 0.7366 | 
      | P-glycoprotein Substrate | Substrate | 0.7011 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8411 | 
                                                     | Non-inhibitor | 0.9457 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9410 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7602 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8447 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8716 | 
      | CYP450 3A4 Substrate | Substrate | 0.6496 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8804 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8703 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9123 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8616 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7923 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5860 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9932 | 
                                                                    | Non-inhibitor | 0.6587 | 
      | AMES Toxicity | Non AMES toxic | 0.8072 | 
      | Carcinogens | Non-carcinogens | 0.8434 | 
      | Fish Toxicity | High FHMT | 0.9971 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9753 | 
      | Honey Bee Toxicity | Low HBT | 0.7137 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | III | 0.8001 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6203 |